Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobuko Kurosaki is active.

Publication


Featured researches published by Nobuko Kurosaki.


Surgery Today | 2001

Surgical Treatment and Subsequent Outcome of Patients with Carcinoma of the Splenic Flexure

Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masaaki Jibiki; Masayuki Ohbatake; Atsushi Nanashima; Hiroyuki Yamaguchi; Toru Yasutake; Nobuko Kurosaki; Hiroyoshi Ayabe; Hiroshi Ishikawa

Abstract Extended resection, comprising extended right hemicolectomy, splenectomy, and distal pancreatectomy, has been advocated for carcinoma of the splenic flexure because the lymphatic drainage at this site is variable. The present study addresses the problems associated with selecting the most appropriate operative procedure to achieve cure of splenic flexure cancers. We conducted a retrospective review of 27 patients with splenic flexure cancer who under-went curative resection. Left partial colectomy was performed in 20 patients and partial resection of the transverse/descending colon was performed in 7 patients. The combined resection of adjacent organs due to tumor adherence was performed in three patients. The spleen and distal pancreas were the organs most frequently resected among a collective total of six adjacent organs. The median duration of follow-up was 60.9 months after resection for splenic flexure cancer. No patient developed local recurrence. There was no significant difference in 5-year survival between patients with splenic flexure cancers and those with colon cancers at other sites. In conclusion, splenic flexure cancer resected by left partial colectomy or partial resection of the transverse/descending colon without routine extended resection was not associated with a worse prognosis than colon cancers at other sites.


Journal of Gastroenterology | 2001

Circulating sialyl Lewis(x), sialyl Lewis(a), and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels.

Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masaaki Jibiki; Atsushi Nanashima; Hiroyuki Yamaguchi; Nobuko Kurosaki; Toru Yasutake; Hiroyoshi Ayabe

Abstract: Preoperative serum levels of sialyl Lewisa (CA 19-9), sialyl Lewisx (SLX), and sialyl Tn (STN) antigens in colorectal cancer patients were examined to establish predictive factors for serum levels of these antigens compared with carcinoembryonic antigen (CEA). A total of 308 patients who underwent resection for a colorectal cancer were divided into low and high antigen groups (higher or lower than a selected diagnostic-based cutoff value). The cutoff values were 37 U/ml for CA19-9, 38 U/ml for SLX, 45 U/ml for STN, and 2.5 ng/ml for CEA. The American Joint Committee on Cancer Classification and Stage grouping was used to classify the tumors. Statistical tests were conducted using univariate and multivariate logistic regression analyses. For CA19-9, 81 patients (26.3%) were assigned to the high antigen group; for SLX, 39 (12.7%); for STN, 33 (10.7%); and for CEA, 133 (43.2%). Multivariate logistic regression analysis revealed that predictive factors associated with high antigen levels were female sex (odds ratio [OR], 1.78 vs male sex), T4 (OR, 3.26 vs T1/T2), and M1 (OR, 3.35 vs M0) for CA19-9; M1 (OR, 6.40 vs M0) for SLX; mucinous carcinoma (OR, 8.45 vs well differentiated adenocarcinoma) and M1 (OR, 8.24 vs M0) for STN; and mucinous carcinoma (OR, 7.21 vs well differentiated adenocarcinoma), T3/T4 (OR, 3.84/4.18, respectively, vs T1/T2), and M1 (OR, 6.39 vs M0) for CEA. In conclusion, high serum levels of CA19-9, SLX, and STN are strongly associated with distant metastasis. In addition, high serum levels of CA19-9 may be an independent predictor for female gender and T4, and high serum levels of STN may be an independent predictor for mucinous carcinoma.


Journal of Human Genetics | 1994

Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinoma

Tadashi Matsumoto; Eiichi Kinoshita; Hidenori Maeda; Norio Niikawa; Nobuko Kurosaki; Naoki Harada; Kankatsu Yun; Tomoko Sawai; Shigeru Aoki; Tatsuro Kondoh; Yoshiro Tsuji

SummaryWe described a patient with Beckwith-Wiedemann syndrome associated with rhabdomyosarcoma (RMS), and renal cell carcinoma (RCC). Karyotypes of peripheral lymphocytes and RMS cells were normal. DNA analyses showed maternal loss of heterozygosity (LOH) at 11p15 region in RMS but not in RCC. The insulin-like growth factor II gene (IGF2) was found to be expressed at a moderate level in RMS but not in RCC by in situ hybridization. Each of parental allele-derived IGF2 transcript was detected in RCC, while maternal allele-derived transcript was weak in RMS because of maternal LOH. These results suggest that (1) loss of imprinting (LOI) of IGF2 might be responsible for BWS, (2) on the other hand, LOI itself might not induce tumor occurrence in tissues where the control of tissue-specific expression of IGF2 is maintained, (3) increased expression of IGF2 due to maternal loss of a putative controller gene for IGF2 at 11p15 might predispose to sustaining tumorigenic mutations and tumor progression, (4) loss of a putative onco-suppressor gene at 11p15 might induce RMS occurrence. The cause of RCC was thought to be different from that of RMS.


Cancer Letters | 2000

Difference in prognostic value between sialyl Lewisa and sialyl Lewisx antigens in blood samples obtained from the drainage veins of the colorectal tumors

Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masaaki Jibiki; Masayuki Ohbatake; Atsushi Nanashima; Hiroyuki Yamaguchi; Nobuko Kurosaki; Toru Yasutake; Hiroyoshi Ayabe; Yutaka Tagawa

Subtraction values, (i.e. values obtained by subtracting the serum titer of sialyl Lewis(a) (CA19-9) and sialyl Lewis(x) (SLX) antigens in peripheral venous blood from the serum titer of the same antigen in the tumors drainage venous blood) were determined in order to clarify whether or not such values for these specific antigens (d-CA19-9 and d-SLX) are prognostic factors after resection for colorectal cancer. The blood samples were obtained from 144 colorectal cancer patients during surgical excisions of the tumors. Univariate and multivariate analyses revealed that d-SLX level was an independent prognostic factor, separate from stage, while d-CA19-9 level did not have any additional prognostic value. In conclusion, a high d-SLX level is a predictor of poor outcome after surgery.


Congenital Anomalies | 1986

A Case of Sacral Parasite

Shigeki Tokunaga; Takayoshi Ikeda; Hiroshi Maeda; Nobuko Kurosaki; Hozumi Shimoda

Abstract A case of sacral parasite is presented. A parasitic body with an incomplete lower limb was attached to the sacrococcygeal region of a female newborn at birth. The twins were easily separated by operation two days after birth. The parasite contained well developed small and/or large intestines, a multilocular cyst and a unilocular cyst. Histologically, the wall of the multilocular cyst consisted of tissues of three germ layers, such as central and peripheral nervous tissues, mature and immature intestine, pancreatic tissue, bronchial cysts, connective tissue, etc. The thick wall of the unilocular cyst consisted of central nervous tissue and connective tissue. The degree of differentiation of these tissues varied considerably. The parasite revealed no organ communication with the autosite. Since the operation, her growth and development have been favorable and no other abnormalities have been found.


Anticancer Research | 2000

Prognostic value of circulating sialyl Tn antigen in colorectal cancer patients.

Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masaaki Jibiki; Atsushi Nanashima; Hiroyuki Yamaguchi; Nobuko Kurosaki; Toru Yasutake; Hiroyoshi Ayabe; Yutaka Tagawa


Acta medica Nagasakiensia | 2000

Prognostic Value of Circulating CA 19-9 in Colorectal Cancer Patients

Tohru Nakagoe; Terumitsu Sawai; Takashi Tsuji; Masaaki Jibiki; Masayuki Ohbatake; Atsushi Nakashima; Hiroyuki Yamaguchi; Nobuko Kurosaki; Toru Yasutake; Hiroyoshi Ayabe; Hiroko Miyashita; Kokichi Arisawa


Acta medica Nagasakiensia | 2000

Biological Differences Between. Polypoid and Nonpolypoid Growth Types of Colorectal Cancer

Tohru Nakagoe; Atsushi Nakashima; Terumitsu Sawai; Takashi Tsuji; Masayuki Ohbatake; Masaaki Jibiki; Hiroyuki Yamaguchi; Nobuko Kurosaki; Toru Yasutake; Hiroyoshi Ayabe; Hiroko Miyashita; Kokichi Arisawa


Acta medica Nagasakiensia | 1994

Esophageal Carcinomas with Synchronous and Metachronous Primary Malignant Carcinomas in Other Organs

Terumitsu Sawai; Akihiro Nakamura; Masaaki Jibiki; Fumitaka Akama; Tetsuya Uchikawa; Nobufumi Sasaki; Hiroshi Shingu; Kazuhiko Hatano; Yosihiro Matsumoto; Masashi Muraoka; Tsutomu Tagawa; Ken Hayashida; Shinya Yamaguchi; Seiichiro Ide; Atsushi Nanashima; Yoshitaka Taniguchi; Naoki Fujise; Nobuko Kurosaki


Acta medica Nagasakiensia | 1998

Delayed Surgery for Congenital Diaphragmatic Hernia

Nobuko Kurosaki; Masayuki Ohbatake; Shuichi Ashizuka; Takashi Hisamatsu; Hiroyoshi Ayabe; Masafumi Fukuda; Hideaki Masuzaki

Collaboration


Dive into the Nobuko Kurosaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge